الاتحاد الأوروبي - الإستونية - EMA (European Medicines Agency)

atnahs pharma netherlands b.v. - macimorelin atsetaat - diagnostika meetodid, sisesekretsioonisüsteemi - macimorelin - see ravim on mõeldud ainult diagnostiliseks kasutamiseks.  ghryvelin is indicated for the diagnosis of growth hormone deficiency (ghd) in adults.

الاتحاد الأوروبي - الإستونية - EMA (European Medicines Agency)

laboratorios hipra, s.a. - live nõrgenenud nakkushaiguste bursal haiguse viiruse (ibdv), tüvi 1052 - immunoloogilised ravimid jaoks linnud, kodukana, live viral vaccines, lindude nakkav bursal haiguse viiruse (gumboro haigus) - chicken; embryonated chicken eggs - aktiivse immuniseerimise 1-ühepäevased tibud, broiler ja embryonated broiler kanamunad, et vähendada kliinilisi tunnuseid ja kahjustused on bursa kohta fabricius, mis on põhjustatud väga virulent lindude nakkav bursal haiguse viirus.

الاتحاد الأوروبي - الإستونية - EMA (European Medicines Agency)

alnylam netherlands b.v. - givosiran - porphyrias, maksa - erinevate alimentary seedetrakti ja ainevahetust tooted - ravi ägeda maksa porfüüria (ahp) täiskasvanud ja noorukid vanuses 12 aastat ja vanemad.

الاتحاد الأوروبي - الإستونية - EMA (European Medicines Agency)

alnylam netherlands b.v. - lumasiran sodium - hyperoxaluria, primary - muud alimentary seedetrakti ja ainevahetust tooted, - treatment of primary hyperoxaluria type 1 (ph1) in all age groups.

الاتحاد الأوروبي - الإستونية - EMA (European Medicines Agency)

incyte biosciences distribution b.v. - pemigatinib - cholangiocarcinoma - antineoplastilised ained - pemazyre monotherapy is indicated for the treatment of adults with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed  after at least one prior line of systemic therapy.

الاتحاد الأوروبي - الإستونية - EMA (European Medicines Agency)

rhythm pharmaceuticals netherlands b.v. - setmelanotide - rasvumine - antiobesioonipreparaadid, va dieedi tooted - imcivree is indicated for the treatment of obesity and the control of hunger associated with genetically confirmed bardet biedl syndrome (bbs), loss-of-function biallelic pro-opiomelanocortin (pomc), including pcsk1, deficiency or biallelic leptin receptor (lepr) deficiency in adults and children 6 years of age and above.

الاتحاد الأوروبي - الإستونية - EMA (European Medicines Agency)

gilead sciences ireland uc - sacituzumab govitecan - breast neoplasms; triple negative breast neoplasms - antineoplastilised ained - trodelvy as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic triple-negative breast cancer (mtnbc) who have received two or more prior systemic therapies, including at least one of them for advanced disease.

الاتحاد الأوروبي - الإستونية - EMA (European Medicines Agency)

beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antineoplastilised ained - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).

أستونيا - الإستونية - Ravimiamet

umedica netherlands b.v. - atorvastatiin - õhukese polümeerikattega tablett - 40mg 14tk; 40mg 60tk; 40mg 50tk; 40mg 10tk; 40mg 98tk; 40mg 84tk; 40mg 90tk; 40mg 20tk

أستونيا - الإستونية - Ravimiamet

umedica netherlands b.v. - atorvastatiin - õhukese polümeerikattega tablett - 10mg 90tk; 10mg 500tk; 10mg 30tk; 10mg 28tk; 10mg 100tk; 10mg 20tk; 10mg 56tk; 10mg 98tk; 10mg 84tk; 10mg 50tk; 10mg 14tk